EN
抗体药类似物
Research Grade Anrukinzumab
All
TD-HW632066_1.jpg
TD-HW632066_2.jpg
  • CatalogTD-HW632066
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsIMA-638, CAS: 910649-32-0
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Anrukinzumab


Catalog No. TD-HW632066
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target IL13, NC30, Interleukin-13, IL-13
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P35225
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names IMA-638, CAS: 910649-32-0
Background Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma.
Note For research use only. Not suitable for clinical or therapeutic use.

 

TD-HW632066_1.jpg
Bioactivity
 
Detects recombinant human IL13 (Cat No.: TD-HW632012) in indirect ELISA.
TD-HW632066_2.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Anrukinzumab.